Advantech EKI-1242IEIMS/EKI-1242EIMS up to 1.06.01 Web Management Interface code injection
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 9.9 | $0-$5k | 0.00 |
Summary
A vulnerability has been found in Advantech EKI-1242IEIMS and EKI-1242EIMS up to 1.06.01 and classified as very critical. This affects an unknown part of the component Web Management Interface. Performing a manipulation results in code injection. This vulnerability is identified as CVE-2026-73166. The attack can be initiated remotely. There is not any exploit available.
Details
A vulnerability classified as very critical has been found in Advantech EKI-1242IEIMS and EKI-1242EIMS up to 1.06.01. This affects an unknown part of the component Web Management Interface. The manipulation with an unknown input leads to a code injection vulnerability. CWE is classifying the issue as CWE-94. The product constructs all or part of a code segment using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the syntax or behavior of the intended code segment. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
Nozomi Networks Labs identified a CWE-94: Improper Control of Generation of Code ('Code Injection') vulnerability in the web management interface of Advantech EKI-1242IEIMS in firmware version V1.06.01 that allows a remote authenticated attacker to execute arbitrary code on the device, including OS commands as root.
It is possible to read the advisory at nozominetworks.com. This vulnerability is uniquely identified as CVE-2026-73166 since 08/11/2026. The exploitability is told to be easy. It is possible to initiate the attack remotely. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $0-$5k at the moment (estimation calculated on 09/16/2026). The attack technique deployed by this issue is T1059 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.advantech.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 9.9VulDB Meta Temp Score: 9.9
VulDB Base Score: 9.9
VulDB Temp Score: 9.9
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Code injectionCWE: CWE-94 / CWE-74 / CWE-707
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
08/11/2026 CVE reserved09/16/2026 Advisory disclosed
09/16/2026 VulDB entry created
09/16/2026 VulDB entry last update
Sources
Vendor: advantech.comAdvisory: nozominetworks.com
Status: Not defined
CVE: CVE-2026-73166 (🔒)
GCVE (CVE): GCVE-0-2026-73166
GCVE (VulDB): GCVE-100-405891
Entry
Created: 09/16/2026 15:36Changes: 09/16/2026 15:36 (64)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.